🟢 ClearOne is trading 10.03% up in after-hours trading after shareholder approval helped de-risk Cortigent merger timeline

ClearOne is trading 10.03% up now at $11.19 after shareholder approval for issuing 12.5 million shares to Vivani Medical helped de-risk the Cortigent merger timeline.

• The approval was a key condition for the Cortigent merger.
• The deal’s substantial dilution remains a major risk.
• ClearOne canceled warrants covering 437,500 shares, streamlining its capital structure.